benzyl (R)-2-methyl-3-phenylpropanoate | 80698-12-0

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: benzyl (R)-2-methyl-3-phenylpropanoate
• 英文别名: Phenylmethyl (I+/-R)-I+/--methylbenzenepropanoate；benzyl (2R)-2-methyl-3-phenylpropanoate
• CAS: 80698-12-0
• 化学式: C₁₇H₁₈O₂
• 分子量: 254.329
• InChiKey: CJUSTKIDRKAPND-CQSZACIVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.61
• 重原子数：
  19.0
• 可旋转键数：
  5.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  26.3
• 氢给体数：
  0.0
• 氢受体数：
  2.0

反应信息

• 作为反应物：
  描述：

  benzyl (R)-2-methyl-3-phenylpropanoate 在 氢气 作用下， 生成 2-methyl-3-phenylpropionic acid
  参考文献：
  名称：

  Asymmetric alkylation reactions of chiral imide enolates. A practical approach to the enantioselective synthesis of .alpha.-substituted carboxylic acid derivatives

  摘要：

  DOI：

  10.1021/ja00370a050
• 作为产物：
  描述：

  ethoxycarbonyl (2R)-2-methyl-3-phenylpropanoate 在 苯甲醇 作用下， 以 四氢呋喃 为溶剂， 反应 1.0h， 生成 benzyl (R)-2-methyl-3-phenylpropanoate
  参考文献：
  名称：

  Asymmetric alkylation reactions of chiral imide enolates. A practical approach to the enantioselective synthesis of .alpha.-substituted carboxylic acid derivatives

  摘要：

  DOI：

  10.1021/ja00370a050

文献信息

• Asymmetric alkylation reactions of camphor-based imide enolate
  作者：Tu-Hsin Yan、Vir-Vir Chu、Ta-Chin Lin、Chih-Hung Wu、Ling-Hsiang Liu

  DOI：10.1016/s0040-4039(00)93507-x

  日期：1991.9

  Alkylations of lithium-chelated imide enolate derived from camphor-based oxazolidone with a variety of alkyl halides provide alkylated products with good to excellent diastereoselectivity.

  衍生自樟脑的恶唑烷酮的螯合锂的酰亚胺烯醇化物与各种烷基卤化物的烷基化为烷基化产物提供了良好或优异的非对映选择性。
• 4-Substituted-5,5-dimethyl oxazolidin-2-ones as effective chiral auxiliaries for enolate alkylations and Michael additions
  作者：Stephen G. Davies、Hitesh J. Sanganee

  DOI：10.1016/0957-4166(95)00057-v

  日期：1995.3

  4-(Methyl, phenyl, benzyl, and i-propyl)-5,5-dimethyl-oxazolidin-2-ones, readily available from α-amino acids, are shown to be effective chiral auxiliaries for stereoselective enolate alkylations and conjugate additions of attached N-acyl moieties.

  4-（甲基，苯基，苄基，和我-丙基）-5,5-二甲基-恶唑烷-2-酮，可容易地从α氨基酸，被证明是有效的立体选择性为烯醇化物烷基化和的共轭加成的手性助剂连接的N-酰基部分。
• Asymmetric aldol and alkylation reactions mediated by the “quat” chiral auxiliary (R)-(−)-5-methyl-3,3-dimethyl-2-pyrrolidinone
  作者：Stephen G. Davies、Gilles J.-M. Doisneau、Jeremy C. Prodger、Hitesh J. Sanganee

  DOI：10.1016/0040-4039(94)85223-5

  日期：1994.4

  Enolates derived from the N-propionoyl derivative of the “quat” chiral auxiliary (R)-(−)-5-methyl-3,3-dimethyl-2-pyrrolidinone undergo highly stereoselective aldol and alkylation reactions. Removal of the auxiliary has been demonstrated with LiOH, PhCH2OLi, MeOMgBr and LiAlH4 to generate respectively (2R,3R)-3-hydroxy-2-methyl-3-phenylpropionic acid in homochiral form, and with 96% e.e. (S)-2-meth

  衍生自“季铵盐”手性助剂（R）-（-）-5-甲基-3,3-二甲基-2-吡咯烷酮的N-丙酰衍生物的烯醇酸酯经历高度立体选择性的羟醛和烷基化反应。已证明可以用LiOH，PhCH 2 OLi，MeOMgBr和LiAlH 4除去助剂，分别生成纯手性形式的（2 R，3 R）-3-羟基-2-甲基-3-苯基丙酸和96％ee （S）-2-甲基-3-苯基丙酸和衍生的甲基和苄基酯，且具有> 94％ee（S）-2-甲基-3-苯基丙醇。
• Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
  申请人：Arimilli N. Murty

  公开号：US20070010489A1

  公开（公告）日：2007-01-11

  Phosphonate substituted compounds with HIV protease inhibitory properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit 5 HIV protease activity and/or are useful therapeutically for the treatment of AIDS and other antiviral infections, as well as in assays for the detection of HIV protease.

  本发明揭示了具有HIV蛋白酶抑制剂性质的膦酸酯取代化合物，其具有作为治疗剂和其他工业用途的用途。该组合物抑制5型HIV蛋白酶活性和/或在治疗艾滋病和其他抗病毒感染方面具有治疗作用，以及在检测HIV蛋白酶方面的检测中有用。
• QUINOLONE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
  申请人：KOGA Yuji

  公开号：US20120136025A1

  公开（公告）日：2012-05-31

  Disclosed are quinolone derivatives characterized in that these have lower alkyl, cycloalkyl or the like at the 1-position; —N(R 0 )C(O)-lower alkylene-CO 2 R 0 , lower alkylene-CO 2 R 0 , lower alkenylene-CO 2 R 0 , —O-lower alkylene-CO 2 R 0 , —O-(lower alkylene which may be substituted with —CO 2 R 0 )-aryl or —O-lower alkenylene-CO 2 R 0 (wherein R 0 is H or lower alkyl) at the 3-position; halogen at the 6-position; and amino group substituted with a substituent group having a ring structure at the 7-position, respectively, or pharmaceutically acceptable salts thereof, has excellent P2Y12 inhibitory activity. The quinolone derivatives have excellent platelet aggregation inhibitory activity. A method of using the compounds is also disclosed.

  本发明涉及喹诺酮衍生物，其特征在于它们在1-位具有较低烷基、环烷基或类似物；在3-位具有-N(R0)C(O)-较低烷基烯基-CO2R0、较低烷基-CO2R0、较低烯基-CO2R0、-O-较低烷基-CO2R0、-O-（可能被取代为-CO2R0的较低烷基）芳基或-O-较低烯基-CO2R0（其中R0为H或较低烷基）；在6-位具有卤素；在7-位具有被环状取代基取代的氨基，或其药学上可接受的盐，具有出色的P2Y12抑制活性。这些喹诺酮衍生物具有优异的血小板聚集抑制活性。本发明还公开了一种使用这些化合物的方法。